Direct activation of human phospholipase C by its well known inhibitor u73122.
Phospholipase C (PLC) enzymes are an important family of regulatory proteins involved in numerous cellular functions, primarily through hydrolysis of the polar head group from inositol-containing membrane phospholipids. U73122 (1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione), one of only a few small molecules reported to inhibit the activity of these enzymes, has been broadly applied as a pharmacological tool to implicate PLCs in diverse experimental phenotypes. The purpose of this study was to develop a better understanding of molecular interactions between U73122 and PLCs. Hence, the effects of U73122 on human PLCβ3 (hPLCβ3) were evaluated in a cell-free micellar system. Surprisingly, U73122 increased the activity of hPLCβ3 in a concentration- and time-dependent manner; up to an 8-fold increase in enzyme activity was observed with an EC50=13.6±5 μm. Activation of hPLCβ3 by U73122 required covalent modification of cysteines as evidenced by the observation that enzyme activation was attenuated by thiol-containing nucleophiles, l-cysteine and glutathione. Mass spectrometric analysis confirmed covalent reaction with U73122 at eight cysteines, although maximum activation was achieved without complete alkylation; the modified residues were identified by LC/MS/MS peptide sequencing. Interestingly, U73122 (10 μm) also activated hPLCγ1 (>10-fold) and hPLCβ2 (∼2-fold); PLCδ1 was neither activated nor inhibited. Therefore, in contrast to its reported inhibitory potential, U73122 failed to inhibit several purified PLCs. Most of these PLCs were directly activated by U73122, and a simple mechanism for the activation is proposed. These results strongly suggest a need to re-evaluate the use of U73122 as a general inhibitor of PLC isozymes.
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599-7360, USA.
Ryan R
RR
Klein
David M
DM
Bourdon
Chester L
CL
Costales
Craig D
CD
Wagner
Wendy L
WL
White
Jon D
JD
Williams
Stephanie N
SN
Hicks
John
J
Sondek
Dhiren R
DR
Thakker
D000595:Amino Acid Sequence; D004789:Enzyme Activation / Q000187:drug effects; D004963:Estrenes / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D010726:Phosphodiesterase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000737:chemistry / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000737:chemistry / Q000378:metabolism*
D004963:Estrenes; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D010738:Type C Phospholipases
J Biol Chem. 2002 Jan 18;277(3):2266-74
11689574
Free Radic Biol Med. 2000 Jun 1;28(11):1671-8
10938464
Mol Pharmacol. 2008 Nov;74(5):1203-14
18682550
J Cell Sci. 2005 Apr 1;118(Pt 7):1427-36
15769849
Nat Chem Biol. 2005 Aug;1(3):154-8
16408020
Annu Rev Biochem. 2001;70:281-312
11395409
Nature. 1990 Feb 22;343(6260):771-4
2106079
Biochem J. 1996 Mar 15;314 ( Pt 3):917-21
8615789
Physiol Rev. 2000 Oct;80(4):1291-335
11015615
Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1207-14
16543494
Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):555-8
11138848
J Biol Chem. 2006 Sep 29;281(39):28499-507
16870611
J Biol Chem. 2007 Mar 2;282(9):6455-62
17194699
J Pharmacol Exp Ther. 1990 May;253(2):688-97
2338654
Cell. 1997 Sep 5;90(5):859-69
9298898
J Membr Biol. 1991 Jun;122(3):193-202
1920385
Biochem J. 2005 Jul 1;389(Pt 1):1-11
15954863
Regul Pept. 2005 Feb 15;125(1-3):179-84
15582730
J Cell Sci. 2005 Jun 15;118(Pt 12):2695-706
15944397
J Mol Biol. 2001 Dec 7;314(4):839-49
11734001
J Biol Chem. 2005 Aug 5;280(31):28402-11
15919658
Mol Pharmacol. 2005 Sep;68(3):847-54
15967877
Cell Signal. 2007 Jan;19(1):42-51
16843639
J Cardiovasc Pharmacol. 2010 Jun;55(6):555-9
20179606
J Gen Physiol. 2005 Sep;126(3):243-62
16129772
Drug Metab Dispos. 2007 Jul;35(7):1017-22
17403917
Science. 1989 May 5;244(4904):546-50
2541501
Br J Pharmacol. 2010 Jul;160(6):1295-301
20590621
J Biol Chem. 1995 May 19;270(20):11872-81
7744837
J Biol Chem. 2005 Sep 2;280(35):30814-28
15994319
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19564-8
17164327
Annu Rev Pharmacol Toxicol. 2006;46:355-79
16402909
Protein Sci. 1995 Jan;4(1):44-57
7773176
J Biol Chem. 1992 Jun 25;267(18):12393-6
1319994
Adv Prostaglandin Thromboxane Leukot Res. 1989;19:590-3
2526542
J Biol Chem. 2002 Sep 20;277(38):35760-5
12101180
Science. 1989 Aug 4;245(4917):528-32
2756432
Chem Biol. 2005 Jun;12(6):649-56
15975510
J Mass Spectrom. 2007 Feb;42(2):139-49
17221927
J Biol Chem. 2006 May 12;281(19):13057-13067
16543237
J Pharmacol Exp Ther. 2004 May;309(2):697-704
14730005
Nature. 2007 Feb 1;445(7127):541-5
17237762
J Cell Sci Suppl. 1993;17:127-32
8144687
J Biol Chem. 2007 May 18;282(20):14861-7
17400548
Biochim Biophys Acta. 2006 Sep;1761(9):995-1013
16931141
Am J Physiol Cell Physiol. 2007 May;292(5):C1775-86
17229814
Cell. 1989 Jun 30;57(7):1167-77
2661017
J Biol Chem. 2005 Nov 18;280(46):38228-34
16166080
Mol Pharmacol. 2005 May;67(5):1751-7
15684042
Clin Biochem. 2005 Sep;38(9):777-91
16005861
J Biol Chem. 1997 Jun 13;272(24):15045-8
9182519
J Biol Chem. 2010 Nov 12;285(46):35836-47
20807769
J Biomed Sci. 2006 Sep;13(5):667-74
16850179
Biochemistry. 1998 May 12;37(19):6615-27
9578545
Biochem Pharmacol. 1998 Dec 1;56(11):1481-4
9827580
J Biol Chem. 2005 Dec 2;280(48):40074-83
16179352
Nat Struct Mol Biol. 2006 Dec;13(12):1135-40
17115053
J Biol Chem. 1991 Dec 15;266(35):23856-62
1660886
Mol Cell. 2008 Aug 8;31(3):383-94
18691970
J Mol Biol. 2003 Mar 7;326(5):1539-47
12595264
Biochemistry. 1997 Dec 16;36(50):15949-58
9398329
J Lipid Res. 2000 Jan;41(1):48-57
10627501
Nat Chem Biol. 2005 Aug;1(3):126-7
16408013
J Biol Chem. 1999 Jun 11;274(24):16995-7002
10358049
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2999-3003
9096335
J Pharmacol Exp Ther. 2003 Feb;304(2):689-98
12538823